Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Immunoadsorption (IA)

Advantages over methylprednisolone in MS patients

    • Neurology
    • RX
    • Studies
  • 3 minute read

Immunoadsorption (IA) shows advantages over methylprednisolone in patients with steroid-refractory acute relapses of multiple sclerosis. An observational study evaluating the efficacy of immunoadsorption (IA) vs. methylprednisolone in patients with steroid-refractory acute relapses of multiple sclerosis demonstrated favorable results for immunoadsorption compared with double-dose methylprednisolone.

While long-term immunomodulatory therapies for multiple sclerosis (MS) have seen significant advances, the treatment approach for acute MS relapses has remained largely unchanged in recent years. Administration of high-dose intravenous methylprednisolone, at up to 1000 mg daily for three to five consecutive days, is recommended as standard treatment. For a majority of patients, this treatment results in symptom relief; however, approximately 25% of patients respond inadequately to the first cycle of methylprednisolone, so current guidelines recommend a second cycle with a double dose of up to 2000 mg daily for three to five consecutive days. Only then should plasma exchange procedures be used in the absence of response. 

Here, an alternative treatment methodology is immunoadsorption (IA), a therapeutic apheresis to remove immunoglobulins. Two prospective and several retrospective studies have demonstrated response rates ranging from 50 to 86% in patients with clinically isolated syndrome (CIS) or relapsing-remitting MS (RMS). These had previously responded inadequately to treatment with methylprednisolone. 

Apheresis treatment is invasive because of the frequent need for a central venous catheter – although very good experience has now been made with a large-lumen peripheral venous catheter – and it is more expensive than methylprednisolone treatment. The mechanisms of action also differ: methylprednisolone treatment targets T cells almost exclusively, whereas IA is used to remove soluble immunoglobulins. “Until now, there has been a lack of groundbreaking comparative studies contrasting the efficacies of apheresis treatment and a second cycle of methylprednisolone in double dosage, thus providing a basis for concretizing (extending) the existing treatment guidelines,” explains Prof. Wiendl, Director of Neurology at Münster University Hospital and spokesperson for the KKNMS Board. 

Pfeuffer and colleagues have now published the data of a prospective clinical study collected within a collaborative project of the university hospitals in Münster and Düsseldorf. Patients with steroid-refractory acute MS were treated with either a 6-cycle tryptophan immunoadsorption or a second cycle of double-dose methylprednisolone. In addition, extensive analyses of cellular and soluble factors in peripheral blood were performed to investigate the effects of both treatments on the immune system.

Data from the 42-patient study show that tryptophan IA (n=16) has a beneficial effect compared with a repeat, higher-dose methylprednisolone pulse (n=26), and that there is a benefit to patients in terms of clinical function scores, health-related QoL (quality of life) scores, and serum NfL levels-not only immediately after treatment, but also at the 3-month follow-up. Flow cytometry measurements revealed a profound reduction in B-cell subsets after IA, which correlated closely with clinical outcomes. 

“In view of these results, it should be considered whether in steroid-refractory MS relapses with a deficit relevant to everyday life, instead of the previously propagated renewed steroid therapy, immunoadsorption should not be connected directly,” said Prof. Dr. Ralf Gold Director of the Neurological University Hospital Bochum and board member of the KKNMS, who has been working for years on the effect of plasma exchange procedures in neuroimmunological diseases. Thus, the results of the study may influence guidelines for escalation therapy of acute MS relapse. 

 

Literature
1. Pfeuffer, S., Rolfes, L., Wirth, T. et al. Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses. J Neuroinflammation 19, 220 (2022). https://doi.org/10.1186/s12974-022-02583-y

 

Original puplication:

Pfeuffer, S., Rolfes, L., Wirth, T. et al. Immunoadsorption versus double-dose methylprednisolone in refractory multiple sclerosis relapses. J Neuroinflammation 19, 220 (2022). https://doi.org/10.1186/s12974-022-02583-y

Previous Article
  • Headache after traumatic brain injury

In one third of those affected, they remain forever

  • Neurology
  • RX
  • Studies
View Post
Next Article
  • Intraepidermal neoplasms

Actinic keratosis – a common precancerous condition

  • Dermatology and venereology
  • Education
  • Oncology
  • Prevention and health care
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 10 min
  • Cutaneous lupus erythematosus

From diagnostic workup to successful treatment

    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
View Post
  • 4 min
  • Guideline update

Dietary recommendations for Crohn’s disease and colitis

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 4 min
  • Circadian rhythm during Ramadan

Disturbed sleep patterns lead to metabolic stress

    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 6 min
  • Case Report

Breast cancer metastases in the bladder

    • Cases
    • Education
    • Gynecology
    • Oncology
    • RX
    • Urology
View Post
  • 11 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
View Post
  • 8 min
  • Efficacy, mechanism of action and clinical effects

Garlic and high blood pressure

    • Cardiology
    • Education
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
View Post
  • 7 min
  • Moderate to severe chronic hand eczema

Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Infectiology
    • Market & Medicine
    • Pharmacology and toxicology
    • RX
View Post
  • 9 min
  • Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CA)

Diagnosis at an early stage, prognostic classifications and outlook

    • Cardiology
    • Education
    • RX
    • Studies
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.